Futura Medical plc (AIM:FUM)

Market Cap	3.89M -85.4%
Revenue (ttm)	7.93M -5.6%
Net Income	-6.29M
EPS	-0.02
Shares Out	581.33M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,542,227
Open	0.6400
Previous Close	0.6700
Day's Range	0.6000 - 0.7820
52-Week Range	0.6000 - 15.0000
Beta	0.01
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 29, 2026

About Futura Medical

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 14
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: FUM